Patients with advanced alveolar soft part sarcoma (ASPS), a rare cancer, achieved some control of their disease using an experimental anti-cancer drug called cediranib. The results from this largest clinical trial on ASPS to date were published in the Journal of Clinical Oncology. Read more here.
Study mentioned: Kummar S, et al. Cediranib for Metastatic Alveolar Soft Part Sarcoma. J Clin Oncol. 2013 Apr 29. [Epub ahead of print] PMID: 23630200
No comments:
Post a Comment